These findings reveal how the cognitive effects of THC are triggered by a pathway which is separate from some of its other effects.

Scientists at the University of East Anglia in collaboration with the University Pompeu Fabra in Barcelona have found a way to separate the medical benefits of cannabis from its unwanted side effects.

Early research suggests that CBD, a substance naturally found in marijuana, is an effective treatment for minimizing the inflammation experienced by asthma sufferers.

The research study found that the studied rats treated with CBD experienced a reduction in two types of cytokines, known as Tp and Th2. In addition to showing that CBD treatment was effective in reducing cytokine levels, the study also suggests that CBD may influence a reduction in the major stimuli of mucus hyper-secretion, another prominent symptom experienced by those with asthma.

BOULDER, Colo. (CBS4) – A Boulder marijuana company says it has a new breakthrough for medical marijuana patients — a marijuana capsule that looks and acts more like traditional pharmaceuticals.

Wana Brands says it now has an alternative to smoking or edible marijuana called Wana Caps.

“We feel like we are making an important step in giving patients another alternative in consuming cannabis,” said Wana Brands owner John Whiteman.

The marijuana maker worked with Cannabics, a pharmaceutical company based in Israel, to develop the first extended release formula to make marijuana last up to 12 hours. The capsules are filled twice — first with a dose that kicks in almost immediately, and then with a dose that starts to work after about four hours.

Marijuana has some incredible pain relief properties. It can also make people incredibly paranoid. A team of biochemists believes it has found a way to separate these two properties and pave the way for a very legal, very helpful new line of medication. And it all began with skunk.

Twenty-four Florida commercial plant nurseries have applied for state licenses to grow non-euphoric marijuana and process and sell a medicinal oil that can be used to treat epilepsy and several other medical conditions in Florida.

The applicants are spread across five regions and their proposals will be competing to win a single license that the state Department of Health will award each region. There are eight applicants who applied for the license for Central Florida. All five regions drew at least four applicants.

Little Sadie Higuera is a model for what it means to fight for one’s life. She’s a testament for what hope and bravery can accomplish in a moment of utmost desperation and she’s living proof of the efficacy of a little green plant we know as cannabis. She’s a gorgeous child with a beautiful heart and we’d like to share her story with you.

The current issue of The Journal of the American Medical Association (JAMA) includes two articles that review studies of marijuana's medical utility and come to similar conclusions about the applications that are best supported by the existing evidence: treatment of chronic pain, neuropathic pain and spasticity.

There is also substantial evidence that THC, marijuana's main active ingredient, is effective at relieving nausea and restoring appetite.

More than two dozen agricultural businesses have submitted applications to the Florida Department of Health in hopes of getting a license to grow low-THC marijuana for medicinal use.

Over one-fifth of those applications are for businesses who want to grow the strain in Northeast Florida.

The Department of Health closed the window for applications Wednesday and 28 businesses submitted requests to get the licenses. Only five licenses to cultivate the drug will be issued, one for each of five geographic regions in the state.

Six applications came from Northeast Florida businesses. Those Northeast Florida agricultural businesses include:

■ Loop’s Nursery & Greenhouses in Jacksonville.

A Wayne County company is among 46 aiming at opening production and distribution facilities across the region. Bill Carey says the people behind the plans say they could change the face of medicine.

No exact date and times have been set, but a series of decisions by state health officials are expected by months' end on where companies will be allowed to set up to grow, develop and sell medical marijuana. 

Various groups have been pressing for the development of the drug. This year, the support finally crystallized behind a plan.

"The medical marijuana law, as enacted in New York state, and signed by Governor Cuomo, is highly restrictive compared to laws in other parts of our nation," said Mark Doherty, CEO of Butler Evergreen.  

One of the most popular topics on the 2015 elections agenda is legalization and cannabis is by far the most widely used illegal drug in the Canada. The interplay between potential legalization models and our current federal medical cannabis system, the Marihuana for Medical Purposes Regulations (MMPR), is important because it will probably shape the direction legalization takes in Canada. Our federal system is unique globally and over one year later, has some important big name interests vested within.